Pharmacogenetics in pediatrics: Implications for practice

Pediatric Clinics of North America

Volumn 44, Issue 1, 1997, Pages 55-77

  Leeder, J S ^a   Kearns, G L ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMITRIPTYLINE; BUDESONIDE; CAPTOPRIL; CISAPRIDE; CLOZAPINE; COTRIMOXAZOLE; COUMARIN ANTICOAGULANT; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DAPSONE; DESIPRAMINE; DIAZEPAM; DICLOFENAC; ERYTHROMYCIN; ETOPOSIDE; FLUCONAZOLE; FLUNARIZINE; LOSARTAN; NIFEDIPINE; ONDANSETRON; PACLITAXEL; PARACETAMOL; PHENYTOIN; RAPAMYCIN; TACROLIMUS; THEOPHYLLINE; THIOPURINE METHYLTRANSFERASE; THIORIDAZINE; TIMOLOL; UNINDEXED DRUG;

CARDIOTOXICITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GENETIC SUSCEPTIBILITY; HUMAN; REVIEW;

EID: 0031041085     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70463-6     Document Type: Article

References (113)

1. Z. Abdel-Razzak L. Corcos A. Fautrel Transforming growth factor-1 down regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture Mol Pharmacol 46 1994 1100
2. Z. Abdel-Razzak P. Loyer A. Fautrel Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture Mol Pharmacol 44 1993 707
3. K. Brosen Drug interactions and the cytochrome P450 system: The role of cytochrome P4501A2 Clin Pharmacokin 29 Suppl 1 1995 20
4. M.A. Butler M. Iwasaki F.P. Guengerich Human cytochrome P450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines Proc Natl Acad Sci USA 86 1989 7696
5. M.A. Butler N.P. Lang J.F. Young Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites Pharmacogenetics 2 1992 116
6. C. Cazeneuve G. Pons E. Rey Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults Br J Clin Pharmacol 37 1994 405
7. K.C. Chang B.A. Lauer T.D. Bell Altered theophylline kinetics during acute respiratory viral illness Lancet i 1978 1132
8. N.W. Cheung C. Liddle S. Coverdale Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man J Clin Endocrinol Metab 81 1996 1999
9. R.T. Coutts P. Su G.B. Baker Involvement of CYP2D6, CYP3A4 and other cytochrome P-450 isozymes in N-dealkylation reactions J Pharmacol Toxicol Meth 31 1994 177
10. A.K. Daly J. Brockmöller F. Broly Nomenclature for human CYP2D6 alleles Pharmacogenetics 6 1996 193
11. P. Dayer T. Leemann R. Striberni Dextromethorphan O -demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity Clin Pharmacol Ther 45 1989 34
12. W.E. Dodson Special pharmacokinetic considerations in children Epilepsia 28 Suppl 1 1987 556
13. D.L. Eaton E.P. Gallagher T.K. Bammler Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity Pharmacogenetics 5 1995 259
14. H. Echizen Y. Ohta H. Shirataki Effects of a subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis Clin Pharmacol Ther 30 1990 562
15. M. Eichelbaum A.S. Gross The genetic polymorphism of debrisoquine/sparteine metabolism: Clinical aspects Pharmacol Ther 46 1990 377
16. L. Ereshefsky C. Riesenman Y.W.F. Lam Antidepressant drug interactions and the cytochrome P450 system: The role of cytochrome P4502D6 Clin Pharmacokin 29 Suppl 1 1995 10
17. W.E. Evans M. Horner Y.Q. Chu Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphoblastic anemia J Pediatr 119 1991 985
18. W.E. Evans M.V. Relling W.P. Petros Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N -acetylation phenotypes in children Clin Pharmacol Ther 45 1989 568
19. D.A. Flockhart Drug interactions and the cytochrome P450 system: The role of cytochrome P4502C19 Clin Pharmacokin 29 Suppl 1 1995 45
20. L.M. Forrester C.J. Henderson M.J. Glancy Relative expression of cytochrome P 450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics Biochem J 281 1992 359
21. S. Fritz W. Lindner I. Roots Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans J Pharmacol Exp Ther 241 1987 615
22. U. Fuhr K. Rost Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and saliva Pharmacogenetics 4 1994 109
23. M. Furlanut G. Montanari P. Bonin Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children J Pediatr 106 1985 491
24. H.J. Gill M.D. Tingle B.K. Park N -Hydroxylation of dapsone by multiple enzymes of cytochrome P450: Implications for inhibition of haemotoxicity Br J Clin Pharmacol 40 1995 531
25. J.A. Goldstein S.M.F. de Morais Biochemistry and molecular biology of the human CYP2C subfamily Pharmacogenetics 4 1994 285
26. J.A. Goldstein M.B. Faletto M. Romkes-Sparks Evidence that CYP2C19 is the major ( S )-mephenytoin 4'-hydroxylase in humans Biochemistry 33 1994 1743
27. F.J. Gonzalez J.R. Idle Pharmacokinetic phenotyping and genotyping: Present status and future potential Clin Pharmacokin 26 1994 59
28. F.J. Gonzalez S.-Y. Liu M. Yano Regulation of cytochrome P450 genes: Molecular mechanisms Pharmacogenetics 3 1993 51
29. E. Hadasova V. Brysova E. Kadlcakova N -Acetylation in healthy and diseased children Eur J Clin Pharmacol 39 1990 43
30. J. Hakkola M. Pasanen R. Purkunen Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver Biochem Pharmacol 48 1994 59
31. E. Jacqz-Aigrain T. Cresteil Cytochrome P450-dependent metabolism of dextromethorphan: Fetal and adult studies Dev Pharmacol Ther 18 1992 161
32. J.H.G. Jonkman K.G. Nicholson P.R. Farrow Effects of α-interferon on theophylline pharmacokinetics and metabolism Br J Clin Pharmacol 27 1989 795
33. W. Kalow B.K. Tang The use of caffeine for enzyme assays: A critical appraisal Clin Pharmacol Ther 53 1993 503
34. R.E. Kauffman G.L. Kearns Pharmacokinetic studies in pediatric patients: Clinical and ethical considerations Clin Pharmacokin 23 1992 10
35. G.R. Kaufmann M. Wenk W. Taeschner N -Acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus Clin Pharmacol Ther 60 1996 62
36. G.L. Kearns Pharmacogenetics and development: Are infants and children at increased risk for adverse outcomes? Curr Opin Pediatr 7 1995 220
37. G.L. Kearns W.R. Crom K.H.J. Karlson Hepatic drug clearance in patients with mild cystic fibrosis Clin Pharmacol Ther 59 1996 529
38. G.L. Kearns J.N. van den Anker Drug metabolism in the neonate and young infant D. Tibboel E. van der Voort Intensive Care in Childhood: A Challenge to the Future (Update in Intensive Care and Emergency Medicine; vol 25) 1996 Springer-Verlag New York 385
39. G.L. Kearns J.G. Wheeler Cefaclor hypersensitivity: A metabolic basis Clin Pharmacol Ther 53 1993 240
40. B.M. Kerr K.E. Thummel C.J. Wurden Human liver carbamazepine metabolism: Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation Biochem Pharmacol 47 1994 1969
41. J.C. Kolars K.C. Lown P. Schmiedlin-Ren CYP3A gene expression in human gut epithelium Pharmacogenetics 4 1994 247
42. R. Korinthenberg C. Haug D. Hannak The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence Neuropediatrics 25 1994 214
43. D.M. Kraus J.H. Fischer S.J. Reitz Alterations in theophylline metabolism during the first year of life Clin Pharmacol Ther 54 1993 351
44. D.L. Kroetz B.M. Kerr L.V. McFarland Measurement of in vivo microsomal epoxide hydrolase activity in white subjects Clin Pharmacol Ther 53 1993 306
45. E.Y. Krynetski J.D. Schuetz A.J. Galpin A single point mutation leading to loss of catalytic activity in human thiopurine S -methyltransferase Proc Natl Acad Sci USA 92 1995 949
46. E.Y. Krynetski H.-L. Tai C.R. Yates Genetic polymorphism of thiopurine S -methyltransferase: Clinical importance and molecular mechanisms Pharmacogenetics 6 1996 279
47. M.G. Ladona B. Lindström C. Thyr Differential foetal development of the O - and N -demethylation of codeine and dextromethorphan in man Br J Clin Pharmacol 32 1991 295
48. G.H. Lambert D.A. Schoeller A.N. Kotake The effect of age, gender, and sexual maturation on the caffeine breath test Dev Pharmacol Ther 9 1986 375
49. R. Lambrecht P. Sinclair N. Gorman Uroporphyrinogen oxidation catalysed by reconstituted cytochrome P4501A2 Arch Biochem Biophys 294 1992 504
50. B.L. Lee D. Wong N.L. Benowitz Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome Clin Pharmacol Ther 53 1993 529
51. J.S. Leeder A.B. Okey Cytochromes P450 and liver injury R.G. Cameron G. Feuer F. de la Iglesia Drug-Induced Hepatotoxicity. (Handbook of Experimental Pharmacology; vol 121) 1996 Springer Berlin 119
52. R.D. Leff L.J. Fischer R.J. Roberts Phenytoin metabolism in infants following intravenous and oral administration Dev Pharmacol Ther 9 1986 217
53. L. Levitsky D. Schoeller G. Lambert Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test Dev Pharmacol Ther 12 1989 90
54. R.H. Levy Cytochrome P450 isozymes and antiepileptic drug interactions Epilepsia 36 suppl 5 1995 8
55. K. Lundström J. Tenhunen C. Tilgmann Cloning, expression and structure of catechol- O -methyltransferase Biochim Biophys Acta 1251 1995 1
56. G. May Genetic differences in drug disposition J Clin Pharmacol 34 1994 881
57. H.L. McLeod E.Y. Krynetski J.A. Wilimas Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults Pharmacogenetics 5 1995 281
58. H.L. McLeod M.V. Relling Q. Liu Polymorphic thiopurine methyltransferase activity in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia Blood 85 1995 1897
59. U.A. Meyer Genetic polymorphisms of drug metabolism Fund Clin Pharmacol 4 1990 595
60. U.A. Meyer Genotype or phenotype: the definition of a pharmacogenetic polymorphism Pharmacogenetics 1 1991 66
61. G. Milavetz L.M. Vaughan M.M. Weinberger Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma J Pediatr 109 1986 351
62. R.P. Miller R.J. Roberts L.J. Fischer Acetaminophen elimination kinetics in neonates, children, and adults Clin Pharmacol Ther 19 1976 284
63. E.G. Nassif M.M. Weinberger D. Shannon Theophylline disposition in infancy J Pediatr 98 1981 158
64. D.R. Nelson T. Kamataki D.J. Waxman The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature DNA Cell Biol 12 1993 1
65. C.B. Nemeroff C.L. DeVane B.G. Pollock Newer antidepressants and the cytochrome P450 system Am J Psychiatry 153 1996 311
66. C.J. Omiecinski L. Aicher L. Swenson Developmental expression of human microsomal epoxide hydrolase J Pharmacol Exp Ther 269 1994 417
67. G.M. Pacifici P. Romiti L. Giuliani Thiopurine methyltransferase in humans: Development and tissue distribution Dev Pharmacol Ther 17 1991 16
68. M.F. Paine D.D. Shen K.L. Kunze First-pass metabolism of midazolam by the human intestine Clin Pharmacol Ther 60 1996 14
69. A. Pariente-Khayat G. Pons E. Rey Caffeine acetylator phenotyping during maturation in infants Pediatr Res 29 1991 492
70. J.O. Park-Hah B. Klemetsdal R. Lysaa Thiopurine methyltransferase activity in a Korean population sample of children Clin Pharmacol Ther 60 1996 68
71. A. Parkinson Biotransformation of Xenobiotics C.D. Klaasen Casarett & Doull's Toxicology. The Basic Science of Poisons ed 5. 1996 McGraw-Hill New York 113
72. D. Peng C. Birgersson C. von Bahr Polymorphic acetylation of 7-aminoclonazepam in human liver cytosol Pediatr Pharmacol 4 1984 155
73. R. Pettignano C.R. Chambliss E. Darsey Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support Crit Care Med 24 1996 1268
74. M. Pirmohamed S. Madden B.K. Park Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism Clin Pharmacokin 31 1996 215
75. A. Rane B. Höjer J.T. Wilson Kinetics of carbamazepine and its 10,11-epoxide metabolite in children Clin Pharmacol Ther 19 1976 276
76. G. Redmond J. Bell P. Nichola Effect of growth hormone on human drug metabolism: Time course and substrate specificity Pediatr Pharmacol 1 1980 63
77. M.V. Relling J. Cherrie M.J. Schell Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects Clin Pharmacol Ther 50 1991 308
78. A.E. Rettie L.C. Wienkers F.J. Gonzalez Impaired ( S )-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9 Pharmacogenetics 4 1994 39
79. M.J. Rieder Mechanisms of unpredictable adverse drug reactions Drug Safety 11 1994 196
80. J.C. Roujeau R.S. Stern Severe adverse cutaneous reactions to drugs N Engl J Med 331 1994 1272
81. B. Schmid J. Bircher R. Presig Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquine hydroxylation Clin Pharmacol Ther 38 1985 618
82. E.G. Schuetz J.D. Schuetz W.M. Grogan Expression of cytochrome P450 3A in amphibian, rat and human kidney Arch Biochem Biophys 294 1992 206
83. J.D. Schuetz D.L. Beach P.S. Guzelian Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver Pharmacogenetics 4 1994 11
84. J. Seidega˚ard W.R. Vorachek R.W. Pero Hereditary differences in the expression of the human glutathione transferase active on trans -stilbene oxide are due to a gene deletion Proc Natl Acad Sci USA 85 1988 7293
85. T. Shimada H. Yamazaki M. Mimura Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 1994 414
86. T. Shimada H. Yamazaki M. Mimura Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs Drug Metab Dispos 24 1996 515
87. C.D. Stowe S.A. Storgion K.R. Lee Severs, acute neurotrauma alters phenytoin (DPH) pharmacokinetics (PK) in children Pediatr Res 39 1996 80
88. J. Strobl M. Thomas Human growth hormone Pharmacol Rev 46 1994 1
89. T.H. Sullivan-Klose B.I. Ghanayem D.A. Bell The role of the CYP2C9 -Leu359 allelic variant in the tolbutamide polymorphism Pharmacogenetics 6 1996 341
90. C. Szumlanski D. Otterness C. Her Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism DNA Cell Biol 15 1996 17
91. C.L. Szumlanski R. Honchel M.C. Scott Human liver thiopurine methyltransferase pharmacogenetics: Biochemical properties, liver erythrocyte correlation and presence of isozymes Pharmacogenetics 2 1992 148
92. H.-L. Tai E.Y. Krynetski C.R. Yates Thiopurine S-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians Am J Hum Genet 58 1996 694
93. F. Takakubo A. Kuwano I. Kondo Evidence that poor metabolizers of ( S )-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese Pharmacogenetics 6 1996 265
94. B.-K. Tang Y. Zhou D. Kadar Caffeine as a probe for CYP1A2 activity: Potential influence of renal factors on urinary phenotypic trait measurements Pharmacogenetics 4 1994 117
95. K. Thummel J. Schenkman Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat Mol Pharmacol 37 1990 119
96. J.-M. Treluyer E. Jacqz-Aigran F. Alvarez Expression of CYP2D6 in developing human liver Eur J Biochem 202 1991 583
97. K.P. Vatsis W.W. Weber D.A. Bell Nomenclature for N -acetyltransferases Pharmacogenetics 5 1995 1
98. M.E. Veronese C.J. Doecke P.I. Mackenzie Site-directed studies of human liver cytochrome P -450 isoenzymes in the CYP2C family Biochem J 289 1993 533
99. L.L. Von Moltke D.J. Greenblatt J. Schmider Metabolism of drugs by cytochrome P4503A isoforms: Implications for drug interactions in psychopharmaclogy Clin Pharmacokin 29 Suppl 1 1995 33
100. P.B. Watkins Noninvasive tests of CYP3A enzymes Pharmacogenetics 4 1994 171
101. P.B. Watkins S.A. Wrighton P. Maurel Identification of an inducible form of cytochrome P-450 in human liver Proc Natl Acad Sci USA 82 1985 6310
102. W.W. Weber D.W. Hein N-Acetylation pharmacogenetics Pharmacol Rev 37 1985 25
103. C.F. Weiss A.J. Glazko J.K. Weston Chloramphenicol in the newborn infant: A physiologic explanation of its toxicity when given in excessive doses N Engl J Med 262 1960 787
104. S.J. Williams J.A. Baird-Lambert G.C. Farrell Inhibition of theophylline metabolism by interferon Lancet ii 1987 939
105. S.A. Wrighton B.J. Ring P.B. Watkins Identification of a polymorphically expressed member of the human cytochrome P-450III family Mol Pharmacol 36 1989 97
106. S.A. Wrighton J.C. Stevens The human hepatic cytochromes P450 involved in drug metabolism CRC Crit Rev Toxicol 22 1992 1
107. S.A. Wrighton J.C. Stevens G.W. Becker Isolation and characterization of human liver cytochrome P450 2C19 - correlation between 2C19 and S-mephenytoin-4'-hydroxylation Arch Biochem Biophys 306 1993 240
108. S.A. Wrighton P.E. Thomas P. Willis Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats J Clin Invest 80 1987 1017
109. S.A. Wrighton M. VandenBranden Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family Arch Biochem Biophys 268 1989 144
110. H.-Y.L. Yang M.J. Namkung M.R. Juchau Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis Biochem Pharmacol 49 1995 717
111. H.-Y.L. Yang Q.P. Lee A.R. Rettie Functional cytochrome P4503A isoforms in human embryonic tissues: Expression during organogenesis Mol Pharmacol 46 1994 922
112. W.S. Young III P.S. Lietman Chloramphenicol glucuronyl transferase: assay, ontogeny and inducibility J Pharmacol Exp Ther 204 1978 203
113. Z.-Y. Zhang L.S. Kaminsky Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation Biochem Pharmacol 50 1995 205